Atara Biotherapeutics (ATRA) News Today

$0.61
+0.01 (+1.67%)
(As of 05/17/2024 ET)
Atara Biotherapeutics: Q1 Earnings Snapshot
Atara Biotherapeutics: Q4 Earnings Insights
Atara Biotherapeutics (NASDAQ:ATRA) Lowered to Sell at StockNews.com
StockNews.com downgraded Atara Biotherapeutics from a "hold" rating to a "sell" rating in a research note on Monday.
Short Interest in Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Declines By 6.7%
Atara Biotherapeutics, Inc. (NASDAQ:ATRA - Get Free Report) was the target of a significant decrease in short interest during the month of February. As of February 29th, there was short interest totalling 10,140,000 shares, a decrease of 6.7% from the February 14th total of 10,870,000 shares. Based on an average daily trading volume, of 3,640,000 shares, the short-interest ratio is currently 2.8 days.
ATRA Apr 2024 0.500 call
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Short Interest Up 44.4% in February
Atara Biotherapeutics, Inc. (NASDAQ:ATRA - Get Free Report) was the recipient of a significant increase in short interest during the month of February. As of February 15th, there was short interest totalling 10,870,000 shares, an increase of 44.4% from the January 31st total of 7,530,000 shares. Based on an average daily volume of 3,690,000 shares, the short-interest ratio is currently 2.9 days.
Atara Biotherapeutics Inc (ATRA)
Atara Biotherapeutics, Inc. (0HIY.L)
Seth Klarman's Exit from Atara Biotherapeutics Inc
Atara Biotherapeutics Inc ATRA
Why Is Atara Biotherapeutics (ATRA) Stock Down 50% Today?
Q3 2023 Atara Biotherapeutics Inc Earnings Call
Get Atara Biotherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATRA and its competitors with MarketBeat's FREE daily newsletter.

Forget Bitcoin: This $8 Stock Is the Next Big Thing (Ad)

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

ATRA Media Mentions By Week

ATRA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ATRA
News Sentiment

0.00

0.43

Average
Medical
News Sentiment

ATRA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ATRA Articles
This Week

0

1

ATRA Articles
Average Week

Get Atara Biotherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATRA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ATRA) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners